TBXT and notochordal tumor: A quarter of people who develop chordomas are heterozygotes for rs2305089 [26, 27], suggesting that a single variant allele contributes to a predisposition to notochordal tumours and likely explains the modest difference in TBXT expression between genotypes in our study.